Kelly, C. M., Bernard, P. S., Krishnamurthy, S., Wang, B., Ebbert, M. T., Bastien, R. R., . . . Pusztai, L. (2012). Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor–Positive Breast Cancer. AlphaMed Press.
Styl cytowania ChicagoKelly, Catherine M., et al. Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor–Positive Breast Cancer. AlphaMed Press, 2012.
Styl cytowania MLAKelly, Catherine M., et al. Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor–Positive Breast Cancer. AlphaMed Press, 2012.